Baishen Pharma Halts Trading on May 25 Amid Control Rights Change Plans

GateNews
According to its announcement on May 24, Baishen Pharma's controlling shareholders are planning a control rights change, the company said. Controlling shareholders Shao Chuneng and Lou Jinfang, along with parties acting in concert with them, are negotiating relevant terms, though the matter remains uncertain. The company's stock will suspend trading from May 25, with a planned halt duration not exceeding two trading days.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments